No supervisor wants to hear that data indicates one of their employees may be diverting controlled substances. However, when they do, every supervisor owes it to their patients and their employees to thoroughly investigate in an effort to confirm or rule out that suspicion. Today’s guests did exactly that. Get an inside look at their thoughts and feelings through the process.
Our guest: Ronald Chapman II, Esq. LLM, Chapman Law Group, Safe Harbor Group In today’s episode we explore crtical issues in healthcare compliance and regulation.
Our guest: Heidi Bragg, MBA, RPh, Drug Diversion Specialist Texas Children’s Hospital Drug diversion monitoring in healthcare often focuses heavily on nursing units, but what
Our guest: Neil Braun, BSC (Pharm), BA (Hons), MPP, Director, PHSA Allied Health Professional Practice Provincial Health Services Authority Drug diversion in healthcare settings is
© Copyright 2023. All Rights Reserved.
